Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson’s Disease
Open Access
- 5 March 2017
- journal article
- review article
- Published by Wiley in Parkinson's Disease
- Vol. 2017, 1-11
Abstract
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease worldwide, affecting more than four million people. Typically, it affects individuals above 45, when they are still productive, compromising both aging and quality of life. Therefore, the cost of the disease must be identified, so that the use of resources can be rational and efficient. Additionally, in Brazil, there is a lack of research on the costs of neurodegenerative diseases, such as PD, a gap addressed in this study. This systematic review critically addresses the various methodologies used in original research around the world in the last decade on the subject, showing that costs are hardly comparable. Nonetheless, the economic and social impacts are implicit, and important information for public health agents is provided.Keywords
This publication has 47 references indexed in Scilit:
- The Direct Cost of Parkinson Disease at Juntendo Medical University Hospital, JapanInternal Medicine, 2016
- Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model AnalysisPLOS ONE, 2015
- Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease – A study from Southwest ChinaParkinsonism & Related Disorders, 2013
- Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's diseaseJournal of the Neurological Sciences, 2012
- Drug and treatment costs in Parkinson’s disease patients in SwedenActa Neurologica Scandinavica, 2011
- Economic burden of Parkinson’s disease in SingaporeEuropean Journal of Neurology, 2010
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, ChinaMovement Disorders, 2006
- Drug costs for patients with Parkinson's disease in two different European countriesActa Neurologica Scandinavica, 2006
- Burden of illness in Parkinson's diseaseMovement Disorders, 2005